SEIZMET G 1

SEIZMET G 1 is a clinically trusted oral anti-diabetic formulation, combining the effectiveness of two powerful agents—Glimepiride and Metformin Hydrochloride. Designed to manage type 2 diabetes mellitus, this dual-action therapy plays a critical role in maintaining optimal blood sugar levels in adults who require more than just dietary control or monotherapy. Manufactured by Steris Healthcare with stringent quality standards, SEIZMET G 1 empowers patients with an affordable and dependable solution for long-term diabetes control.

What is Glimepiride and Metformin HCl?

Glimepiride and Metformin HCl tablets are a combination medication used to treat type 2 diabetes. Glimepiride helps the pancreas release more insulin, while Metformin reduces the amount of sugar produced by the liver and improves how the body uses insulin. This synergistic mechanism enhances glycemic control and reduces the risk of complications associated with poorly managed diabetes, such as kidney damage, vision loss, and nerve problems.

Uses of Glimepiride Metformin HCl Tablets

SEIZMET G 1 is primarily prescribed for the management of type 2 diabetes in patients who do not achieve adequate glycemic control with Glimepiride or Metformin alone. It is often used as part of a comprehensive treatment plan that includes a proper diet and regular exercise.
Common therapeutic uses include:

• Improving glycemic control in adults with type 2 diabetes

• Delaying the progression of diabetic complications

• Helping to lower HbA1c levels over time

• Enhancing insulin sensitivity and secretion

Side Effects of SEIZMET G 1

Like all medications, Glimepiride and Metformin may cause some side effects. While most are mild and temporary, some may require medical attention if persistent.
Common side effects include:

• Nausea or stomach discomfort

• Headache

• Dizziness

• Hypoglycemia (low blood sugar), especially if meals are skipped

• Diarrhea or abdominal bloating
  Rare but serious side effects:

• Lactic acidosis (a rare but serious condition linked to Metformin)

• Allergic skin reactions

• Impaired liver function

Precautions Before Using Glimepiride Metformin HCl Tablets

Before starting SEIZMET G 1, it is important to consider the following precautions:

• Inform your doctor if you have kidney, liver, or heart problems

• Avoid alcohol as it increases the risk of lactic acidosis and hypoglycemia

• Regular monitoring of blood sugar levels, renal function, and HbA1c is recommended

• This medicine is not recommended for type 1 diabetes or diabetic ketoacidosis

• Use with caution in elderly patients and those with a history of sulfa drug allergy

Drug Interactions

SEIZMET G 1 may interact with several medications and substances. Be sure to inform your healthcare provider of all drugs you are taking.
Drugs that may interact include:

• Beta-blockers (e.g., propranolol), which may mask symptoms of hypoglycemia

• Diuretics and corticosteroids, which may increase blood sugar levels

• ACE inhibitors, which may enhance the hypoglycemic effect

• Antifungal agents like miconazole

• Insulin or other oral antidiabetics, which may increase the risk of low blood sugar

• Iodinated contrast agents used in imaging procedures, which may increase the risk of lactic acidosis

Conclusion

SEIZMET G 1 (Glimepiride 1 mg + Metformin HCl 500 mg) is a reliable, evidence-based solution for the effective management of type 2 diabetes. By combining insulin secretagogue and insulin sensitizer properties, this formulation offers a comprehensive approach to glycemic control. When used responsibly under medical supervision, it improves the quality of life and helps patients take confident steps toward a healthier future. Always consult your healthcare provider for personalized advice before starting or changing your diabetes treatment plan.